NDC 0641-6044-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6044
- Requested NDC
- 0641-6044-01
- Package NDCs from labels
- 0641-6044-01, 0641-6044-25
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Injection, USP | REMEDYREPACK INC. | 2024-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - TYA Pharmaceuticals | TYA Pharmaceuticals | 2011-11-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6044-01 | Lorazepam | 1 mL in 1 VIAL | INJECTION | 1 | 10 | |
| 0641-6044-25 | Lorazepam | 25 in 1 CARTON | INJECTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6044-01 | ML - Milliliter | 0641-6044 | 9c10d57c-be4d-4e5c-bd04-680c477d6ef8 | 1 | 2012-07-24 |
| 0641-6044-25 | ML - Milliliter | 0641-6044 | 6e34d5a1-9495-43ce-a1cb-9f6626a83af7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LORAZEPAM | LORAZEPAM | Advanced Rx of Tennessee, LLC | 2a57e549-390b-5482-e063-6394a90aeb3b | 2024-12-28 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Glitch Advanced Relief Eye Drops | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL | Misemer Pharmaceutical, Inc | 03778509-3374-2168-e063-6294a90a9505 | 2024-12-23 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 29f63525-2839-946c-e063-6294a90aebb1 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 6DC9Q167V3 |
| ITCH X | BENZYL ALCOHOL/PRAMOXINE HYDROCHLORIDE | BF ASCHER AND CO INC | 03c16d33-8f59-0184-e054-00144ff8d46c | 2024-12-05 | Warnings | LKG8494WBH |
| Salonpas LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Hisamitsu America, Inc. | 364924d3-fac3-4f4e-9b40-decd4ec48245 | 2024-12-03 | Warnings | LKG8494WBH |
| Salonpas LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Hisamitsu America, Inc. | ea5b4a7f-d47d-4dbd-9288-c01329e387e5 | 2024-12-03 | Warnings | LKG8494WBH |
| Orajel Toothache Rinse | BENZYL ALCOHOL, ZINC CHLORIDE | Church & Dwight Co., Inc. | 41709710-5392-3119-e054-00144ff88e88 | 2024-11-27 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | b2487467-a63f-48b5-b0de-3a6ce6672d50 | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | 1665188 O26FZP769L |
| Instant Hand Sanitizeing Wipe | ISOPROPANOL AND COMPOUND DOUBLE-STRANDED QUATERNARY AMMONIUM SALTS | Shandong Yayun Sanitary Products Co., Ltd. | aa0dc01a-2c6b-7402-e053-2a95a90af6a2 | 2024-11-21 | Warnings | 6DC9Q167V3 |
| Baby Wipes | PROPYLENE GLYCOL | Shandong Yayun Sanitary Products Co., Ltd. | aeb9a12c-955f-5030-e053-2995a90a2dd6 | 2024-11-20 | Warnings | 6DC9Q167V3 |
| Meijer Pain Lidocaine Plus Relieving Analgesic | BENZYL ALCOHOL AND LIDOCAINE HYDROCHLORIDE | Meijer Distribution, Inc | b7385140-3f63-4cbc-b557-de1d29d1ea36 | 2024-11-15 | Warnings | LKG8494WBH |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | a9a90de6-3172-4d34-984b-f4442f880e3d | 2024-11-13 | Warnings | B697894SGQ |
| Visine Dry Eye Relief | POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | 2de7a41d-661d-495f-89b4-5690664a3a3d | 2024-11-13 | Warnings | B697894SGQ |
| Visine Dry Eye Relief Eye Drops | POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | d9d3f000-3ce4-4ba2-a7fb-491b44eb3fa1 | 2024-11-13 | Warnings | B697894SGQ |
| Visine Dry Eye Relief | POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | a4c57620-778f-4434-9105-ead2f85c5884 | 2024-11-13 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 503834f9-fa2e-5e23-e054-00144ff88e88 | 2024-11-13 | Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | be85b116-9f09-403a-8e0d-e77e344d3a9a | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Acme United Corporation | f19fbe28-b928-7c6e-e053-2995a90a43cb | 2024-11-09 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | Chartwell RX, LLC | 6b0619c5-b9e9-47e7-97b5-7e581e67cf5f | 2024-11-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.